{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:45:16Z","timestamp":1789872316103,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Activated Protein C (aPC) plays dual roles after injury, driving both trauma-induced coagulopathy (TIC) by cleaving, and thus inactivating, factors Va and VIIIa and depressing fibrinolysis while also mediating an inflammomodulatory milieu via protease activated receptor-1 (PAR-1) cytoprotective signaling. Because of this dual role, it represents and ideal target for study and therapeutics after trauma. A known aPC variant, 3K3A-aPC, has been engineered to preserve cytoprotective activity while retaining minimal anticoagulant activity rendering it potentially ideal as a cytoprotective therapeutic after trauma. We hypothesized that 3K3A-aPC would mitigate the endotheliopathy of trauma by protecting against endothelial permeability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We used electric cell-substrate impedance sensing to measure permeability changes in real time in primary endothelial cells. These were cultured, grown to confluence, and treated with a 2 \u03bcg\/mL solution of 3K3A-aPC at 180 minutes, 120 minutes, 60 minutes, 30 minutes prior to stimulation with ex vivo plasma taken from severely injured trauma patients (Injury Severity Score &gt; 15 and BD &lt; \u22126) (trauma plasma [TP]). Cells treated with thrombin and untreated cells were included in this study as control groups. Permeability changes were recorded in real time via electric cell-substrate impedance sensing for 30 minutes after treatment with TP. We quantified permeability changes in the control and treatment groups as area under the curve (AUC). Rac1\/RhoA activity was also compared between these groups. Statistical significance was determined by one-way ANOVA followed by a post hoc analysis using Tukey's multiple comparison's test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Treatment with aPC mitigated endothelial permeability induced by ex vivo trauma plasma at all pre-treatment time points. The AUC of the 30-minute 3K3A-aPC pretreatment group was higher than TP alone (mean diff. 22.12 95% CI [13.75, 30.49],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001) (Figure). Moreover, the AUC of the 60-minute, 120-minute, and 180-minute pretreatment groups was also higher than TP alone (mean diff., 16.30; 95% confidence interval [CI], 7.93\u201324.67; 19.43; 95% CI, 11.06\u201327.80, and 18.65; 95% CI, 10.28\u201327.02;, all\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001, respectively). Rac1\/RhoA activity was higher in the aPC pretreatment group when compared with all other groups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Pretreatment with 3K3A-aPC, which retains its cytoprotective function but has only ~5% of its anticoagulant function, abrogates the effects of trauma-induced endotheliopathy. This represents a potential therapeutic treatment for dysregulated thromboinflammation for injured patients by minimizing aPC's role in trauma-induced coagulopathy while concurrently amplifying its essential cytoprotective function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n                    <jats:p>Prognostic and Epidemiological; Level III.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000004142","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:00:42Z","timestamp":1695297642000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Mitigation of trauma-induced endotheliopathy by activated protein C: A potential therapeutic for postinjury thromboinflammation"],"prefix":"10.1097","volume":"96","author":[{"given":"Otto","family":"Thielen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchayita","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Debot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Schaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren T.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Cralley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Silliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sauaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mosnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"5","key":"bib1-20250806","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/01.sla.0000256862.79374.31","article-title":"Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?","volume":"245","year":"2007","journal-title":"Ann Surg"},{"issue":"6","key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/SHK.0b013e3181a5a632","article-title":"Increase in activated protein C mediates acute traumatic coagulopathy in mice","volume":"32","year":"2009","journal-title":"Shock"},{"issue":"6","key":"bib3-20250806","first-page":"1176","article-title":"Protein C depletion early after trauma increases the risk of ventilator-associated pneumonia","volume":"67","year":"2009","journal-title":"J Trauma"},{"issue":"2","key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/SLA.0b013e318235d9e6","article-title":"Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients","volume":"255","year":"2012","journal-title":"Ann Surg"},{"issue":"8","key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","year":"2007","journal-title":"Blood"},{"issue":"3","key":"bib6-20250806","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1165\/rcmb.2010-0397OC","article-title":"Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa\u2013induced lung injury in mice","volume":"45","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 1(0 1)","key":"bib7-20250806","first-page":"242","article-title":"Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway","volume":"11","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"6","key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1182\/blood-2004-01-0110","article-title":"Activated protein C variants with normal cytoprotective but reduced anticoagulant activity","volume":"104","year":"2004","journal-title":"Blood"},{"issue":"8","key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1538-7836.2012.04825.x","article-title":"Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects","volume":"10","year":"2012","journal-title":"J Thromb Haemost"},{"key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1538-7836.2007.02491.x","article-title":"Activated protein C","volume":"5","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"bib11-20250806","first-page":"S25","article-title":"Acute traumatic coagulopathy: clinical characterization and mechanistic investigation","volume":"133","year":"2014","journal-title":"Thromb Res"},{"issue":"Pt B","key":"bib12-20250806","first-page":"242","article-title":"New understandings of post injury coagulation and resuscitation","volume":"33","year":"2016","journal-title":"Int J Surg"},{"issue":"Suppl 1(Suppl 1)","key":"bib13-20250806","first-page":"S263","article-title":"Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more","volume":"153","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"2","key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection","volume":"132","year":"2018","journal-title":"Blood"},{"issue":"10","key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe Sepsis","volume":"344","year":"2001","journal-title":"N Engl J Med"},{"issue":"26","key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","year":"2012","journal-title":"Blood"},{"issue":"45","key":"bib17-20250806","doi-asserted-by":"crossref","first-page":"33022","DOI":"10.1074\/jbc.M705824200","article-title":"Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin Activable fibrinolysis inhibitor-dependent Cytoprotective functions","volume":"282","year":"2007","journal-title":"J Biol Chem"},{"issue":"8","key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1182\/blood-2004-10-3985","article-title":"Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation","volume":"105","year":"2005","journal-title":"Blood"},{"issue":"6","key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/SHK.0000000000002008","article-title":"Shock induces endothelial permeability after trauma through increased activation of Rhoa Gtpase","volume":"58","year":"2022","journal-title":"Shock"},{"issue":"14","key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis","volume":"276","year":"2001","journal-title":"J Biol Chem"},{"key":"bib21-20250806","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway","volume":"296","year":"2002","journal-title":"Science"},{"issue":"3","key":"bib22-20250806","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nm826","article-title":"Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective","volume":"9","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"bib23-20250806","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1073\/pnas.0611493104","article-title":"Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells","volume":"104","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"15","key":"bib24-20250806","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1073\/pnas.0810687106","article-title":"Caveolae are required for protease-selective signaling by protease-activated receptor\u20131","volume":"106","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"bib25-20250806","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","year":"1991","journal-title":"Cell"},{"issue":"8","key":"bib26-20250806","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"6801","key":"bib27-20250806","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","year":"2000","journal-title":"Nature"},{"key":"bib28-20250806","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0896-6273(04)00019-4","article-title":"Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3","volume":"41","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.25383","article-title":"Final results of the RHAPSODY trial: a multi-center, phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human activated protein C, in combination with tissue plasminogen activator, mechanical thrombectomy or both in moderate to severe acute ischemic stroke","volume":"85","year":"2019","journal-title":"Ann Neurol"},{"issue":"Suppl 1(Suppl 1)","key":"bib30-20250806","first-page":"S55","article-title":"Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw","volume":"69","year":"2010","journal-title":"J Trauma"},{"issue":"5","key":"bib31-20250806","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/SHK.0000000000001378","article-title":"Resuscitative strategies to modulate the endotheliopathy of trauma: from cell to patient","volume":"53","year":"2020","journal-title":"Shock"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:08:12Z","timestamp":1754496492000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004142","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}